Clinical Trial Update: Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating etoposide plus cisplatin in recurrent ependymoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Mayo Clinic | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED